Fact Sheet
21-Aug-08
lycos14
I began my career as an Analyst for an asset management in July 2006 after graduating Magna Cum Laude from Loyola College in Baltimore. Prior to gradu... more
Latest Blog Post
Best of breed (12-Aug-08)
Few can doubt the success of JNJ's business model. The firm has tremendous brand recognition, and despite poor performance on their pharma segment, earnings estimates continue to move higher (especially after their Q2 results in mid July).
JNJ's top line may never again grow faster than 10%, but with continued cost containment (pardon the alliteration) and share buybacks, EPS growth in the low t...... View Blog
| lycos14 | S&P 500 | |
|---|---|---|
| Return Since Inception | -0.86 | |
| Month to Date Return | -0.86 | 0.56 |
| Last 3 Months Return | -5.82 | -8.53 |
| Last 12 Months Return | -4.80 | -12.91 |
| Annualized Return | -0.73 | 0.44 |
| Alpha (%) | 0.04 | |
| Beta | 0.83 | |
Latest Trades
Login to track lycos14 and view trades.
Risk
| Annualized Std. Deviation | Sharpe Ratio | Maximum Drawdown | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
lycos14
S&P 500 lycos14's Latest Commentary
|
Updated JNJ rationale. 12-Aug-08 | |
|
Asked jfabrega a question. 31-Jul-08 | |
|
Created a TEX blog post. 30-Jul-08 | |
|
Created a BUCY blog post. 30-Jul-08 | |
|
Created a FAF blog post. 30-Jul-08 | |
| More | ||

Talk to lycos14
Log in to ask this member a question
Previous questions
|
glenncorliss asked (02-Feb-08)
Hi Mark, I'm new to Covestor, and while reviewing members' profiles, I came across your comments on ... More
|
|
Don_Bartell asked (09-Jan-08)
|

